Conclusion
We conducted a large sample of retrospective active monitoring study, to explore clinical characteristics, incidence, drug distribution and risk factors of drug-associated muscle adverse reactions. Result of this research could make us be more aware of such adverse reactions, to improve the benefit of medication to patients and minimize the risk of muscle injury.